Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Schmidt

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Brain Research|July 31, 1995
Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressantS P Rossby, I Nalepa, M Huang, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligandK A Neve, R A Henningsen, J M Kinzie, et al.
Archives of Biochemistry and Biophysics|July 1, 1996
Elevations of hepatic quinone reductase, glutathione, and alpha- and mu-class glutathione S-transferase isoforms in mice with chronic hepatitis: a compensatory response to injuryC L Fernandes, J H Dong, B D Roebuck, et al.
Chemical & Pharmaceutical Bulletin|January 20, 1998
Synthesis and radiolabeling of (S)-4-amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the active enantiomer of [125I]iodozacopride, and re-evaluation of its 5-HT3 receptor affinityW A Hewlett, T de Paulis, N S Mason, et al.
Pharmacology, Biochemistry, and Behavior|August 18, 2001
Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-mazeZ J Zhang, D E Schmidt, T de Paulis, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 31, 2016
CC chemokine ligands in patients presenting with stable chest pain: association with atherosclerosis and future cardiovascular eventsM O Versteylen, M Manca, I A Joosen, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptorsW A Hewlett, B L Trivedi, Z J Zhang, et al.
Life Sciences|January 1, 1991
High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptorsR M Kessler, M S Ansari, D E Schmidt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1991
High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamidesR M Kessler, M S Ansari, T de Paulis, et al.
European Journal of Pharmacology|November 13, 1992
Visualization of extrastriatal dopamine D2 receptors in the human brainR M Kessler, N S Mason, J R Votaw, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Brain Research|July 31, 1995
Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressantS P Rossby, I Nalepa, M Huang, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligandK A Neve, R A Henningsen, J M Kinzie, et al.
Archives of Biochemistry and Biophysics|July 1, 1996
Elevations of hepatic quinone reductase, glutathione, and alpha- and mu-class glutathione S-transferase isoforms in mice with chronic hepatitis: a compensatory response to injuryC L Fernandes, J H Dong, B D Roebuck, et al.
Chemical & Pharmaceutical Bulletin|January 20, 1998
Synthesis and radiolabeling of (S)-4-amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the active enantiomer of [125I]iodozacopride, and re-evaluation of its 5-HT3 receptor affinityW A Hewlett, T de Paulis, N S Mason, et al.
Pharmacology, Biochemistry, and Behavior|August 18, 2001
Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-mazeZ J Zhang, D E Schmidt, T de Paulis, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 31, 2016
CC chemokine ligands in patients presenting with stable chest pain: association with atherosclerosis and future cardiovascular eventsM O Versteylen, M Manca, I A Joosen, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptorsW A Hewlett, B L Trivedi, Z J Zhang, et al.
Life Sciences|January 1, 1991
High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptorsR M Kessler, M S Ansari, D E Schmidt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1991
High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamidesR M Kessler, M S Ansari, T de Paulis, et al.
European Journal of Pharmacology|November 13, 1992
Visualization of extrastriatal dopamine D2 receptors in the human brainR M Kessler, N S Mason, J R Votaw, et al.
Pageof 10